Activist Group Raises Evogene Stake to 19.35% with $350K in New Purchases
EVGN sits 76% above its 52-week low of $0.37 on light trading volume (0.2× avg).
Summary
Activist investor L.I.A. Pure Capital and its group increased their Evogene stake to 19.35% with $350K in new open-market purchases, intensifying the board battle.
Key Events · Ownership and Investor Activity · EVGN
-
Stake Increased to 19.35%
The activist group led by L.I.A. Pure Capital acquired 533,088 additional ADSs, raising its aggregate beneficial ownership from 17.41% to 19.35% of Evogene's outstanding shares.
-
Purchases Total ~$350K
The new shares were bought in open-market transactions between August 7 and August 10, 2026, at prices ranging from $0.55 to $0.71 per ADS, totaling approximately $350,000.
-
Proxy Fight Intensifies
This is the fourth amendment to the group's Schedule 13D since July 10, 2026, reflecting continued accumulation as the group seeks to replace most of Evogene's board at the upcoming annual meeting.
-
Voting Power Consolidation
The group now holds shared voting power over 3,057,488 shares, representing 19.35% of the company, up from 17.41% previously.
Analysis · EVGN · Industrial Applications And Services
The activist group seeking to replace Evogene's board has increased its stake to 19.35% from 17.41%, buying 533,088 ADSs for approximately $350,000. This is the fourth amendment in a month, showing continued accumulation and escalating pressure on the company. The group now holds nearly one-fifth of the company, strengthening its position in the proxy fight.
At the time of this filing, EVGN was trading at $0.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.3M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.